Skip to main content

Find Clinical Trials

Home
Conditions
Sensation Disorders

Clinical trial condition

Sensation Disorders

Explore clinical trials studying Sensation Disorders. Study availability and eligibility vary by location and protocol.

66 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Sensation Disorders trial results

Active, Not Recruiting

Multichannel Vestibular Implant Early Feasibility Study

NCT02725463

Conditions: Bilateral Vestibular Deficiency (BVD), Bilateral Vestibulopathy, Chemically-Induced Disorders, +18 more
Locations: Johns Hopkins School of Medicine Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

Treatment of Olfactory Dysfunction Using Vagus Nerve Stimulation

NCT06817499

Conditions: Anosmia, Hyposmia, Nervous System Diseases, +5 more
Locations: Karolinska Institutet Solna, Stockholm County, Sweden

View Trial Details

Active, Not Recruiting

Effects of an Online Hearing Support for First-time Hearing Aid Users

NCT06051968

Conditions: Ear Diseases, Hearing Disability, Hearing Disorders, +8 more
Locations: Audiologimottagningen Lund Lund, Sweden

View Trial Details

Active, Not Recruiting

Sensory Profile and Academic Achievement in Students

NCT06659432

Conditions: Nervous System Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, +3 more
Locations: Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation Ankara, Turkey (Türkiye)

View Trial Details

Active, Not Recruiting

Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)

NCT02935517

Conditions: Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
Locations: VitreoRetinal Associates Gainesville, Florida, United States

Bascom Palmer Eye Institute Miami, Florida, United States

Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States

Cincinnati Eye Institute Cincinnati, Ohio, United States

View Trial Details

Active, Not Recruiting

A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)

NCT03913143

Conditions: Blindness, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations: University of Iowa Iowa City, Iowa, United States

Universitair Ziekenhuis Gent (UZ) Ghent, Belgium

INRET Clínica/ Santa Casa de Misericórdia de Belo Horizonte Belo Horizonte, Minas Gerais, Brazil

Federal University of São Paulo - Hospital São Paulo (UNIFESP-HSP) São Paulo, Brazil

View all 14 locations

View Trial Details